Rapport Therapeutics, Inc. · NASDAQ:RAPP
Silva Paul M bought 3,680 Rapport Therapeutics, Inc. shares (Form 4)
Traded Oct 22, 2026 · Filed Oct 22, 2026
On Oct 22, 2026, Silva Paul M (Director) bought 3,680 Rapport Therapeutics, Inc. shares at US$27.08 for US$99,636, leaving 3,680 shares. Filed Oct 22, 2026 (Form 4).
- Bought
- 3,680 shares
- Price
- US$27.08
- Value
- US$99,636
- Holding after
- 3,680 shares (held indirectly)
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 22, 2026 | Common Stock | Buy | 3,680 | US$27.08 | 3,680 | Indirect |
Source
Download original · View original at SEC